How should iRhythm balance increasing the wear time of Zio monitors for more comprehensive data versus patient comfort and adherence?

Introduction

The challenge at hand is balancing the increased wear time of iRhythm's Zio monitors for more comprehensive data against patient comfort and adherence. This trade-off is crucial for iRhythm's product strategy, as it directly impacts the quality of cardiac monitoring data and the user experience. I'll analyze this problem through the lens of product strategy, user experience, and technical feasibility.

Step 1

Clarifying Questions (3 minutes)

• Based on the current market position, I'm thinking this trade-off might be driven by competitive pressures. Could you provide more context on our market share and key competitors?

Why it matters: Helps understand the urgency and strategic importance of this decision. Expected answer: We're facing increased competition from new entrants with longer-wear devices. Impact on approach: Would influence the aggressiveness of our wear time extension efforts.

• Considering user segments, I'm assuming we have data on patient adherence rates. Can you share insights on how adherence varies across different patient groups or wear durations?

Why it matters: Identifies potential targeted approaches for different user segments. Expected answer: Adherence drops significantly after 7 days for most users. Impact on approach: Would guide the optimal wear time target and potential personalization strategies.

• From a technical perspective, I'm curious about the current limitations of our device. What are the primary factors limiting extended wear time?

Why it matters: Helps identify the key areas for innovation and improvement. Expected answer: Battery life and adhesive durability are the main constraints. Impact on approach: Would focus our efforts on specific technical improvements.

• Regarding our product roadmap, how does this initiative align with other planned features or improvements?

Why it matters: Ensures this effort is coordinated with broader product strategy. Expected answer: It's a top priority for the next two quarters. Impact on approach: Would influence resource allocation and timeline considerations.